Moderna is developing vaccines against viral diseases including vaccines against acute respiratory infections, vaccines against persistent infections, as well as vaccines against threats to global public health.
Moderna has also filed to the US Food and Drug Administration for a final approval of its vaccine on June 1, and expects to complete its submission in August.
Washington: A third booster shot of US pharmaceutical Moderna’s Covid vaccine can rapidly increase the level of antibodies in previously inoculated people, according to data from its Phase 2 study.…
New York: US-based drugmaker Moderna on Monday said its Covid-19 vaccine retains neutralising activity against emerging variants first identified in the UK and South Africa. Vaccination with the Moderna Covid-19 Vaccine produced neutralising titers against all key emerging variants tested, including B.1.1.7 and B.1.351, first identified in the UK and South Africa, respectively, the company […]
New Delhi: Following accounts of potential allergies to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, scientists have outlined steps on safely receiving the second dose of the therapeutic in individuals who develop a reaction to their first dose. The research, published in the Journal of Allergy and Clinical Immunology: In Practice, summarised what is […]
New York: The US government has entered into a $1.5 billion deal with biotechnology company Moderna for the manufacturing and delivery of 100 million doses of its potential Covid-19 vaccine, mRNA-1273. With the previous award of up to $955 million for the development of the vaccine to licensure, the new announcement brings the US government’s […]
New York: Pharmaceutical company Moderna’s Covid-19 vaccine, which is currently in clinical trials, has shown successful results in monkeys. Two doses of an experimental vaccine known as mRNA-1273 induced robust immune responses and rapidly controlled the Covid-19 in the upper and lower airways of Monkeys exposed to SARS-CoV-2, the National Institute of Allergy and Infectious […]